Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma

Molecular and Cellular Proteomics

Volumn 7, Issue 9, 2008, Pages 1639-1650

  Wang, Zhi ^a   Jiang, Lu ^a   Huang, Canhua ^b   Li, Zhengyu ^b   Chen, Lijuan ^b   Gou, Lantu ^b   Chen, Ping ^b   Tong, Aiping ^b   Tang, Minghai ^b   Gao, Feng ^a   Shen, Jun ^a   Zhang, Yuanyuan ^a   Bait, Jingping ^a   Zhou, Min ^a   Miao, Di ^a   Chen, Qianming ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECEPTOR FOR ACTIVATED C KINASE 1; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; EPITHELIUM DYSPLASIA; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; METASTASIS; MOUTH CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TISSUE DIFFERENTIATION; UPREGULATION;

EID: 52649147563     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M700520-MCP200     Document Type: Article

References (35)

1. Parkin, D. M. (2001) Global cancer statistics in the year 2000. Lancet Oncol. 2, 533-543
2. Fearlay, J., Bray, F., Pisani, P., and Parkin, D. M. (2001) Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Cancer Base No. 5, International Agency for Research on Cancer (IARC) Press, Lyon, France
3. Funk, G. F., Karnell, L. H., Robinson, R. A., Zhen, W. K., Trask, D. K., and Hoffman, H. T. (2002) Presentation, treatment, and outcome of oral cavity cancer. a National Cancer Data Base report. Head Neck 24, 165-180
4. Herrmann, P. C., Liotta, L. A., and Petricoin, E. F., III (2001) Cancer proteomics: the state of the art. Dis. Markers 17, 49-57
5. Johann, D. J., Jr., McGuigan, M. D., Patel, A. R., Tomov, S., Ross, S., Conrads, T. P., Veenstra, T. D., Fishman, D. A., Whiteley, G. R., Petricoin, E. F., III, and Liotta, L. A. (2004) Clinical proteomics and biomarker discovery. Ann. N. Y. Acad. Sci. 1022, 295-305
6. Turhani, D., Krapfenbauer, K., Thumher, D., Langen, H., and Fountoulakis, M. (2006) Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27, 1417-1423
7. He, Q. Y., Chen, J., Kung, H. F., Yuen, A. P., and Chiu, J. F. (2004) Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4, 271-278
8. Lo, W. Y., Tsai, M. H., Tsai, Y., Hua, C. H., Tsai, F. J., Huang, S. Y., Tsai, C. H., and Lai, C. C. (2007) Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin. Chim. Acta 376, 101-107
9. Lo, W. Y., Lai, C. C., Hua, C. H., Tsai, M. H., Huang, S. Y., Tsai, C. H., and Tsai, F. J. (2007) S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J. Proteome Res. 6, 2143-2151
10. Lee, E. J., Kim, S. H., Kwark, Y. E., and Kim, J. (2006) Heterogeneous nuclear ribonuclear protein C is increased in the celecoxib-induced growth inhibition of human oral squamous cell carcinoma. Exp. Mol. Med. 38, 203-209
11. Schrohl, A. S., Holten-Andersen, M., Sweep, F., Schmitt, M., Harbeck, N., Foekens, J., and Brünner, N. European Organisation for Research and Treatment of Cancer (EORTC) Receptor and Biomarker Group (2003) Tumor markers: from laboratory to clinical utility. Mol. Cell. Proteomics 2, 378-387
12. Kavallaris, M., and Marshall, G. M. (2005) Proteomics and disease: opportunities and challenges. Med. J. Aust. 182, 575-579
13. Sobin, L. H., and Wittekind, Ch. (eds) (2002) UICC TNM Classification of Malignant Tumors, 6th Ed., John Wiley and Sons, Inc., New York
14. Kreisberg, J. I., Malik, S. N., Prihoda, T. J., Bedolla, R. G., Troyer, D. A., Kreisberg, S., and Ghosh, P. M. (2004) Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res. 64, 5232-5236
15. Zhu, K., Zhao, J., Lubman, D. M., Miller, F. R., and Barder, T. J. (2005) Protein pl shifts due to posttranslational modifications in the separation and characterization of proteins. Anal. Chem. 77, 2745-2755
16. McCahill, A., Warwicker, J., Bolger, G. B., Houslay, M. D., and Yarwood, S. J. (2002) The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol. Pharmacol. 62, 1261-1273
17. Srinivas, P. R., Kramer, B. S., and Srivastava, S. (2001) Trends in biomarker research for cancer detection. Lancet Oncol. 2, 698-704
18. Rodrigo, J. P., Ferlito, A., Suarez, C., Shaha, A. R., Silver, C. E., Devaney, K. O., Bradley, P. J., Bocker, J. M., McLaren, K. M., Grenman, R., and Rinaldo, A. (2005) New molecular diagnostic methods in head and neck cancer. Head Neck 27, 995-1003
19. Zhao, J., Chang, A. C., Li, C., Shedden, K. A., Thomas, D. G., Misek, D. E., Giordano, T. J., Beer, D. G., and Lubman, D. M. (2007) Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping. Mol. Cell. Proteomics 6, 294-304
20. Roessler, M., Rollinger, W., Mantovani-Endl, L., Hagmann, M. L., Palme, S., Berndt, P., Engel, A. M., Pfeffer, M., Karl, J., Bodenmuller, H., Ruschoff, J., Henkel, T., Rohr, G., Rossol, S., Rosch, W., Langen, H., Zolg, W., and Tacke, M. (2006) Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol. Cell. Proteomics 5, 2092-2101
21. Moubayed, N., Weichenthal, M., Harder, J., Wandel, E., Sticherling, M., and Glaser, R. (2007) Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J. Cancer Res. Clin. Oncol. 133, 253-261
22. Alfonso, P., Dolado, I., Swat, A., Nunez, A., Cuadrado, A., Nebreda, A. R., and Casal, J. I. (2006) Proteomic analysis of p38alpha mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblasts. Proteomics 6, Suppl. 1, 262-271
23. Jang, J. S., Cho, H. Y., Lee, Y. J., Ha, W. S., and Kim, H. W. (2004) The differential proteome profile of stomach cancer identification of the biomarker candidates. Oncol. Res. 14, 491-499
24. Hu, L., Lu, F., Wang, Y., Liu, Y., Liu, D., Jiang, Z., Wan, C., Zhu, B., Gan, L., Wang, Y., and Wang, Z. (2006) RACK1, a novel hPER1-interacting protein. J. Mol. Neurosci. 1, 55-63
25. ε to integrin β chains: requirements for adhesion and motility. J. Biol. Chem. 277, 22073-22084
26. Steele, M. R., McCahill, A., Thompson, D. S., MacKenzie, C., Isaacs, N. W., Houslay, M. D., and Bolger, G. B. (2001) Identification of a surface on the β-propeller protein RACK1 that interacts with the cAMP-specific phosphodiesterase PDE4D5. Cell. Signal. 13, 507-513
27. Chang, B. Y., Chiang, M., and Cartwright, C. A. (2001) The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1. J. Biol. Chem. 276, 20346-20356
28. Baumann, M., Gires, O., Kolch, W., Mischak, H., Zeidler, R., Pich, D., and Hammerschmidt, W. (2000) The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1. Eur. J. Biochem. 267, 3891-3901
29. Gallina, A., Rossi, F., and Milanesi, G. (2001) Rack1 binds HIV-1 Nef and can act as a Nef-protein kinase C adaptor. Virology 283, 7-18
30. Hermanto, U., Zong, C. S., Li, W., and Wang, L. H. (2002) RACK1, an insulin-like growth factor I (IGF-1) receptor-interacting protein, modulates IGF-1-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol. Cell. Biol. 22, 2345-2365
31. Berns, H., Humar, R., Hengerer, B., Kiefer, F. N., and Battegay, E. J. (2000) RACK1 is up-regulated in angiogenesis and human carcinomas. FASEB J. 14, 2549-2558
32. Carolina, M. H., Kay, D., Pamela, K., Musa, M., Karin, N., Dennis, S., George, S., and Frances, M. V. (2007) Shaping the future of biomarker research in breast cancer to ensure clinical relevance. Nat. Rev. Cancer 7, 309-315
33. Kubota, T., Yokosawa, N., Yokota, S., and Fujii, N. (2002) Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the α interferon receptor complex. J. Virol. 76, 12676-12682
34. Fomenkov, A., Zangen, R., Huang, Y. P., Osada, M., Guo, Z., Fomenkov, T., Trink, B., Sidransky, D., and Ratovitski, E. A. (2004) RACK1 and stratifin target ΔNp63α for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle 3, 1285-1295
35. Ryther, R. C., Flynt, A. S., Phillips, J. A., III, and Patton, J. G. (2005) siRNA therapeutics: big potential from small RNAs. Gene Ther. 12, 5-11